{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:05:09Z","timestamp":1792854309929,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02611-6","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T21:23:27Z","timestamp":1748813007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome"],"prefix":"10.1186","volume":"30","author":[{"given":"Pin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2611_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"2611_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13817","volume":"52","author":"X Tang","year":"2022","unstructured":"Tang X, Wu M, Wu S, Tian Y. Continuous metabolic syndrome severity score and the risk of CVD and all-cause mortality. Eur J Clin Invest. 2022;52: e13817.","journal-title":"Eur J Clin Invest"},{"key":"2611_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539\u201353.","journal-title":"Diabet Med"},{"key":"2611_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.molmed.2013.05.001","volume":"19","author":"G Cildir","year":"2013","unstructured":"Cildir G, Akincilar SC, Tergaonkar V. Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol Med. 2013;19:487\u2013500.","journal-title":"Trends Mol Med"},{"key":"2611_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177\u201385.","journal-title":"Nature"},{"key":"2611_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17:306\u201321.","journal-title":"Nat Rev Immunol"},{"key":"2611_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98\u2013107.","journal-title":"Nat Rev Immunol"},{"key":"2611_CR8","first-page":"302","volume":"77","author":"A Cagnina","year":"2022","unstructured":"Cagnina A, Chabot O, Davin L, Lempereur M, Marechal P, Oury C, et al. Atherosclerosis, an inflammatory disease. Rev Med Liege. 2022;77:302\u20139.","journal-title":"Rev Med Liege"},{"key":"2611_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","volume":"49","author":"S Sookoian","year":"2008","unstructured":"Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008;49:600\u20137.","journal-title":"J Hepatol"},{"key":"2611_CR10","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1093\/eurheartj\/ehl207","volume":"27","author":"DY Hu","year":"2006","unstructured":"Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China heart survey. Eur Heart J. 2006;27:2573\u20139.","journal-title":"Eur Heart J"},{"key":"2611_CR11","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","volume":"368","author":"KH Yoon","year":"2006","unstructured":"Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681\u20138.","journal-title":"Lancet"},{"key":"2611_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/amj.2018.03.11","volume":"3","author":"R Hu","year":"2018","unstructured":"Hu R, Xie Y, Lu B. Metabolic inflammatory syndrome: a novelconcept of holistic integrative medicine for management of metabolic diseases. AME Med J. 2018;3:51.","journal-title":"AME Med J"},{"issue":"9","key":"2611_CR13","first-page":"960","volume":"31","author":"R Hu","year":"2016","unstructured":"Hu R. Concept and clinical significance of metabolic inflammatory syndrome. Clin Focus. 2016;31(9):960\u20133.","journal-title":"Clin Focus"},{"issue":"3","key":"2611_CR14","first-page":"380","volume":"44","author":"R Li","year":"2017","unstructured":"Li R, Hu R. Progress in the pathogenesis of metabolic inflammatory syndrome. Fudan Univ J Med Sci. 2017;44(3):380\u20134.","journal-title":"Fudan Univ J Med Sci"},{"key":"2611_CR15","first-page":"27","volume":"32","author":"R Hu","year":"2016","unstructured":"Hu R, Xie Y, Lu B, et al. High detective rate of \u201cmetabolic inflammatory syndrome\u201d in patients with type 2 diabetes. Chin J EndocrinolMetab. 2016;32:27\u201332.","journal-title":"Chin J EndocrinolMetab"},{"key":"2611_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3945\/ajcn.112.056333","volume":"98","author":"GJ van Woudenbergh","year":"2013","unstructured":"van Woudenbergh GJ, Theofylaktopoulou D, Kuijsten A, Ferreira I, van Greevenbroek MM, van der Kallen CJ, et al. Adapted dietary inflammatory index and its association with a summary score for low-grade inflammation and markers of glucose metabolism: the cohort study on diabetes and atherosclerosis maastricht (CODAM) and the hoorn study. Am J Clin Nutr. 2013;98:1533\u201342.","journal-title":"Am J Clin Nutr"},{"key":"2611_CR17","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.2147\/DMSO.S291612","volume":"14","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhou XL, Mei GH, Wang J, Yu Z, Hu Y, et al. Serum heparanase: a new clinical biomarker involved in senile metabolic inflammatory syndrome. Diabetes Metab Syndr Obes. 2021;14:3221\u20138.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2611_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","volume":"14","author":"JS Marshall","year":"2018","unstructured":"Marshall JS, Warrington R, Watson W, Kim HL. An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol. 2018;14:49.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2611_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/1570161118666200318104434","volume":"19","author":"D Patoulias","year":"2021","unstructured":"Patoulias D, Stavropoulos K, Imprialos K, Athyros V, Grassos H, Doumas M, et al. Inflammatory markers in cardiovascular disease; lessons learned and future perspectives. Curr Vasc Pharmacol. 2021;19:323\u201342.","journal-title":"Curr Vasc Pharmacol"},{"key":"2611_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/JIR.S283835","volume":"14","author":"Z Jin","year":"2021","unstructured":"Jin Z, Wu Q, Chen S, Gao J, Li X, Zhang X, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131\u201340.","journal-title":"J Inflamm Res"},{"key":"2611_CR21","doi-asserted-by":"publisher","first-page":"15129","DOI":"10.1038\/s41598-024-66152-4","volume":"14","author":"X Yin","year":"2024","unstructured":"Yin X, Zhang Y, Zou J, Yang J. Association of the systemic immune-inflammation index with all-cause and cardiovascular mortality in individuals with rheumatoid arthritis. Sci Rep. 2024;14:15129.","journal-title":"Sci Rep"},{"key":"2611_CR22","doi-asserted-by":"publisher","first-page":"2197652","DOI":"10.1080\/07853890.2023.2197652","volume":"55","author":"E Zhao","year":"2023","unstructured":"Zhao E, Cheng Y, Yu C, Li H, Fan X. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease. Ann Med. 2023;55:2197652.","journal-title":"Ann Med"},{"key":"2611_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12020-023-03587-1","volume":"84","author":"C Yang","year":"2024","unstructured":"Yang C, Yang Q, Xie Z, Peng X, Liu H, Xie C. Association of systemic immune-inflammation-index with all-cause and cause-specific mortality among type 2 diabetes: a cohort study base on population. Endocrine. 2024;84:399\u2013411.","journal-title":"Endocrine"},{"key":"2611_CR24","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1210\/clinem\/dgac176","volume":"107","author":"W Zhou","year":"2022","unstructured":"Zhou W, Li S, Sun G, Song L, Feng W, Li R, et al. Early warning of Ischemic stroke based on atherosclerosis index combined with serum markers. J Clin Endocrinol Metab. 2022;107:1956\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"2611_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/joim.13069","volume":"288","author":"B Zou","year":"2020","unstructured":"Zou B, Yeo YH, Nguyen VH, Cheung R, Ingelsson E, Nguyen MH. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999\u20132016. J Intern Med. 2020;288:139\u201351.","journal-title":"J Intern Med"},{"key":"2611_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States national health and nutrition examination survey. Aliment Pharmacol Ther. 2015;41:65\u201376.","journal-title":"Aliment Pharmacol Ther"},{"key":"2611_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"key":"2611_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12933-024-02396-8","volume":"23","author":"HM He","year":"2024","unstructured":"He HM, Xie YY, Chen Q, Li YK, Li XX, Mu YK, et al. The additive effect of the triglyceride-glucose index and estimated glucose disposal rate on long-term mortality among individuals with and without diabetes: a population-based study. Cardiovasc Diabetol. 2024;23:307.","journal-title":"Cardiovasc Diabetol"},{"key":"2611_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13098-024-01402-z","volume":"16","author":"D Zhang","year":"2024","unstructured":"Zhang D, Shi W, An T, Li C, Ding Z, Zhang J. Usefulness of estimated glucose disposal rate in detecting heart failure: results from national health and nutrition examination survey 1999\u20132018. Diabetol Metab Syndr. 2024;16:189.","journal-title":"Diabetol Metab Syndr"},{"key":"2611_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/HYPERTENSIONAHA.108.120154","volume":"53","author":"P Muntner","year":"2009","unstructured":"Muntner P, Krousel-Wood M, Hyre AD, Stanley E, Cushman WC, Cutler JA, et al. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines. Hypertension. 2009;53:617\u201323.","journal-title":"Hypertension"},{"key":"2611_CR31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860\u20137.","journal-title":"Nature"},{"key":"2611_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.pcd.2023.11.001","volume":"18","author":"R Li","year":"2024","unstructured":"Li R, Lu B, Li Q, Hu J, Huang Y, Wang Y, et al. Characteristics of metabolic inflammatory syndrome among inpatients with type 2 diabetes: a cross-sectional study in China. Prim Care Diabetes. 2024;18:97\u2013103.","journal-title":"Prim Care Diabetes"},{"key":"2611_CR33","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/01.STR.0000124122.71702.64","volume":"35","author":"AJ Grau","year":"2004","unstructured":"Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147\u201352.","journal-title":"Stroke"},{"key":"2611_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0002-9149(99)00272-6","volume":"84","author":"HA Cooper","year":"1999","unstructured":"Cooper HA, Exner DV, Waclawiw MA, Domanski MJ. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the studies of left ventricular dysfunction [SOLVD]). Am J Cardiol. 1999;84:252\u20137.","journal-title":"Am J Cardiol"},{"key":"2611_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clinbiochem.2017.11.008","volume":"52","author":"CH Dong","year":"2018","unstructured":"Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis. Clin Biochem. 2018;52:131\u20136.","journal-title":"Clin Biochem"},{"key":"2611_CR36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.5603\/KP.a2017.0068","volume":"75","author":"H Li","year":"2017","unstructured":"Li H, Zhou Y, Ma Y, Han S, Zhou L. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis. Kardiol Pol. 2017;75:666\u201373.","journal-title":"Kardiol Pol"},{"key":"2611_CR37","doi-asserted-by":"publisher","first-page":"655701899","DOI":"10.1177\/03000605231204469","volume":"51","author":"M Vakhshoori","year":"2023","unstructured":"Vakhshoori M, Nemati S, Sabouhi S, Shakarami M, Yavari B, Emami SA, et al. Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis. J Int Med Res. 2023;51:655701899.","journal-title":"J Int Med Res"},{"key":"2611_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1590\/0004-282x20190001","volume":"77","author":"A Tekesin","year":"2019","unstructured":"Tekesin A, Tunc A. Inflammatory markers are beneficial in the early stages of cerebral venous thrombosis. Arq Neuropsiquiatr. 2019;77:101\u20135.","journal-title":"Arq Neuropsiquiatr"},{"key":"2611_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bj.2020.06.010","volume":"44","author":"MI Edilova","year":"2021","unstructured":"Edilova MI, Akram A, Abdul-Sater AA. Innate immunity drives pathogenesis of rheumatoid arthritis. Biomed J. 2021;44:172\u201382.","journal-title":"Biomed J"},{"key":"2611_CR40","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/life13071469","volume":"13","author":"M Gonzalez-Sierra","year":"2023","unstructured":"Gonzalez-Sierra M, Quevedo-Rodriguez A, Romo-Cordero A, Gonzalez-Chretien G, Quevedo-Abeledo JC, de Vera-Gonzalez A, et al. Relationship of blood inflammatory composite markers with cardiovascular risk factors and subclinical atherosclerosis in patients with rheumatoid arthritis. Life. 2023;13:1469.","journal-title":"Life"},{"key":"2611_CR41","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.2147\/IJGM.S413538","volume":"16","author":"H Li","year":"2023","unstructured":"Li H, Meng S, Chen W, Lei X, Kong X, Zhu H. Comparison of different systemic inflammatory markers in predicting clinical outcomes with syntax score in patients with non-st segment elevation myocardial infarction: a retrospective study. Int J Gen Med. 2023;16:2595\u2013607.","journal-title":"Int J Gen Med"},{"key":"2611_CR42","doi-asserted-by":"publisher","first-page":"2656920","DOI":"10.1177\/17588359231212184","volume":"15","author":"A Passardi","year":"2023","unstructured":"Passardi A, Azzali I, Bittoni A, Marisi G, Rebuzzi F, Molinari C, et al. Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab. Ther Adv Med Oncol. 2023;15:2656920.","journal-title":"Ther Adv Med Oncol"},{"key":"2611_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12967-023-03924-y","volume":"21","author":"L Meng","year":"2023","unstructured":"Meng L, Yang Y, Hu X, Zhang R, Li X. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. J Transl Med. 2023;21:79.","journal-title":"J Transl Med"},{"key":"2611_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13230","volume":"50","author":"YL Yang","year":"2020","unstructured":"Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50: e13230.","journal-title":"Eur J Clin Invest"},{"key":"2611_CR45","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1080\/07853890.2022.2083671","volume":"54","author":"K Han","year":"2022","unstructured":"Han K, Shi D, Yang L, Wang Z, Li Y, Gao F, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54:1667\u201377.","journal-title":"Ann Med"},{"key":"2611_CR46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s40001-023-01446-3","volume":"28","author":"YW Huang","year":"2023","unstructured":"Huang YW, Zhang Y, Feng C, An YH, Li ZP, Yin XS. Systemic inflammation response index as a clinical outcome evaluating tool and prognostic indicator for hospitalized stroke patients: a systematic review and meta-analysis. Eur J Med Res. 2023;28:474.","journal-title":"Eur J Med Res"},{"key":"2611_CR47","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/JIR.S451190","volume":"17","author":"D Zhu","year":"2024","unstructured":"Zhu D, Wang C, Zhou Y, Che H, Wang R, Cheng L, et al. The associations of two novel inflammation biomarkers, SIRI and SII, with mortality risk in patients with chronic heart failure. J Inflamm Res. 2024;17:1255\u201364.","journal-title":"J Inflamm Res"},{"key":"2611_CR48","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/s41598-024-51878-y","volume":"14","author":"X Deng","year":"2024","unstructured":"Deng X, Liu D, Li M, He J, Fu Y. Association between systemic immune-inflammation index and insulin resistance and mortality. Sci Rep. 2024;14:2013.","journal-title":"Sci Rep"},{"key":"2611_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13098-023-01178-8","volume":"15","author":"F Kong","year":"2023","unstructured":"Kong F, Huang J, Xu C, Huang T, Wen G, Cheng W. System inflammation response index: a novel inflammatory indicator to predict all-cause and cardiovascular disease mortality in the obese population. Diabetol Metab Syndr. 2023;15:195.","journal-title":"Diabetol Metab Syndr"},{"key":"2611_CR50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612\u20136.","journal-title":"Science"},{"key":"2611_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s40001-023-01529-1","volume":"28","author":"H Wang","year":"2023","unstructured":"Wang H, Nie H, Bu G, Tong X, Bai X. Systemic immune-inflammation index (SII) and the risk of all-cause, cardiovascular, and cardio-cerebrovascular mortality in the general population. Eur J Med Res. 2023;28:575.","journal-title":"Eur J Med Res"},{"key":"2611_CR52","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1007\/s00125-007-0785-y","volume":"50","author":"EL Ding","year":"2007","unstructured":"Ding EL, Song Y, Manson JE, Rifai N, Buring JE, Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia. 2007;50:2076\u201384.","journal-title":"Diabetologia"},{"key":"2611_CR53","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","volume":"295","author":"EL Ding","year":"2006","unstructured":"Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288\u201399.","journal-title":"JAMA"},{"key":"2611_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/iid3.404","volume":"9","author":"G Costagliola","year":"2021","unstructured":"Costagliola G, Spada E, Consolini R. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19. Immun Inflamm Dis. 2021;9:331\u20139.","journal-title":"Immun Inflamm Dis"},{"key":"2611_CR55","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00011-020-01372-8","volume":"69","author":"GH Meftahi","year":"2020","unstructured":"Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of \u201cinflame-aging.\u201d Inflamm Res. 2020;69:825\u201339.","journal-title":"Inflamm Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02611-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02611-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02611-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T23:12:36Z","timestamp":1748819556000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02611-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2611"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02611-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Health and Nutrition Examination Survey (NHANES) is conducted under the auspices of the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (NCHS). To maintain the highest ethical standards, the NHANES research protocol is subject to a stringent review process and receives authorization from the NCHS Research Ethics Review Board. In addition, in compliance with established ethical protocols, written informed consent is obtained from all participants involved in the NHANES study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"444"}}